• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

tariffs

A sign reading tariffs in front of a stock ticker and the US Capitol building
Manufacturing

Trump rekindles pharmaceutical tariff threat: Reuters

Following months of handwringing from the industry, President Donald Trump has renewed threats of pharmaceutical-specific import tariffs.
Fraiser Kansteiner Jun 17, 2025 11:21am
UCB logo on flag

UCB touts plan for 'major' US manufacturing investment

Jun 12, 2025 1:34pm
Albert Bourla

Pfizer CEO calls for NATO-like drug spending commitments

Jun 10, 2025 11:26am
capsules money profits finances tariffs

Drugmakers, trade groups and others hit back on tariff threat

May 29, 2025 10:50am
Trump

Large pharmas likely to endure Trump's pricing, tariff threats: S&P

May 28, 2025 11:16am
Houston Texas Houston TX

Lilly weighs Houston as option for new $5.9B API facility

May 19, 2025 10:21am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings